Literature DB >> 20041381

Results of total hip arthroplasties in the young patient; further evidence for a barrier against articular wear debris by hydroxyapatite coatings.

Pieter J Emans1, Rene H M Ten Broeke, Jeroen M J Van Mulken, Roel Kuijer, Lodewijk W Van Rhijn, Rudolph G T Geesink.   

Abstract

We examined the hypothesis that the circumferential osseous apposition around HA-coated implants forms a protective barrier against articular wear debris. Sixty-five hydroxyapatite-coated total hip arthroplasties in 57 patients (age <50years) with polyethylene-metal articulation were evaluated regarding PE-wear, osteolysis, and clinical outcome at a minimum of 10 years follow-up. There was no correlation between PE-wear and osteolysis of the femoral zones or cup zones I and III. A strong Pearson correlation was found between polyethylene wear and osteolysis around cup zone II, where the cup only consisted of polyethylene (p<0,01). The aseptic failure rate was 1.5% for the femoral component and 4.5% for the cup after 10 years of follow-up. The average Harris Hip Score was 90 and the average Engh score for fixation was 23 after 10 years . Around HA-coated parts of the prosthesis bone formation remained stable, regardless of the degree of polyethylene wear. The average linear polyethylene wear was 0,16 mm/year. The circumferential osseous apposition of the HA-coated implants possibly formed a protective barrier against articular wear debris. The use of cups with a backside gap resulted in PE-wear associated osteolysis in cup zone II and may be considered to be best avoided.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20041381     DOI: 10.1177/112070000901900408

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  1 in total

1.  Cementless hydroxyapatite coated hip prostheses.

Authors:  Antonio Herrera; Jesús Mateo; Jorge Gil-Albarova; Antonio Lobo-Escolar; Elena Ibarz; Sergio Gabarre; Yolanda Más; Luis Gracia
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.